Amylyx Pharmaceuticals Cash Flow Statement 2020-2025 | AMLX

Fifteen years of historical annual cash flow statements for Amylyx Pharmaceuticals (AMLX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212020
$-301.74$49.27$-198.38$-87.93$-42.28
$-8.95$-8.85$-1.57$0.17$0.00
$189$37.16$21.71$8.36$2.98
$180$28.31$20.15$8.54$2.98
$39.60$-24.74$-15.31$0$0
$-9.25$-73.13$-9.77$0$0
$-19.10$15.88$1.85$0.67$1.42
$2.73$-5.27$-4.47$-4.51$-0.76
$-45.83$-65.66$-1.64$4.60$2.60
$-167.65$11.92$-179.87$-74.80$-36.70
$-36.36$-1.24$-2.53$-0.35$-0.15
$0$0$0$0$0
$0$0$0$0$0
$112$93.29$-236.46$-46.05$0
$0$0$0$0$0
$112$93.29$-236.46$-46.05$0
$0$0$0$0$0
$75.65$92.05$-238.99$-46.41$-0.15
$0$0$0$25.90$16.82
$0$0$0$0$0
$0$0$0$25.90$16.82
$2.13$6.86$435$0.34$0.05
$2.13$6.86$435$135$30.01
$0$0$0$0$0
$-1.78$-3.32$-2.85$-2.73$0
$0.35$3.54$432$159$46.82
$-92.08$108$12.87$37.31$9.98
$33.04$37.16$21.71$3.14$0.24
$0$0$0$0$0